Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
2 recherche sur le mot-clé 'healthcare utilization'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Effects of sex, race, and ethnicity on primary and subspecialty healthcare use by autistic children in Florida: A longitudinal retrospective cohort study (2012?2018) / Amber M. ANGELL in Research in Autism Spectrum Disorders, 94 (June 2022)
[article]
Titre : Effects of sex, race, and ethnicity on primary and subspecialty healthcare use by autistic children in Florida: A longitudinal retrospective cohort study (2012?2018) Type de document : Texte imprimé et/ou numérique Auteurs : Amber M. ANGELL, Auteur ; Deepthi S. VARMA, Auteur ; Alexis DEAVENPORT-SAMAN, Auteur ; Larry YIN, Auteur ; Olga SOLOMON, Auteur ; Chen BAI, Auteur ; Baiming ZOU, Auteur Article en page(s) : 101951 Langues : Anglais (eng) Mots-clés : Autism spectrum disorders Sex/gender Healthcare utilization Index. décimale : PER Périodiques Résumé : Background Autistic children and youth have high rates of co-occurring conditions,but little is known about how autism subgroups (girls, non-White children) access healthcare to treat them. The purpose of this longitudinal retrospective cohort study was to investigate differences by sex, race, and ethnicity in non-acute (primary and subspecialty) healthcare use by autistic children and youth. Method We used the OneFlorida Data Trust to measure healthcare use for 82,566 autistic children ages 1?21 (2012?2018). We investigated (1) the odds of using any healthcare and (2) annual healthcare usage rates. We adopted a logistic regression and multiple linear regression for each of the dependent variables (total non-acute, primary care, gastroenterology (GI), developmental-behavioral pediatrics (DBP), psychiatry/psychology, neurology, and total subspecialty visits), adjusting for potential confounders (sex, race, ethnicity, age at visit, insurance type, urbanicity, and co-occurring conditions). Results Autistic boys had significantly higher odds of any neurology and psychiatry/psychology visits, but lower annual rates of primary care, GI, and neurology visits. Black/African American autistic children had significantly higher odds of any primary care, DBP, and neurology visits, but lower odds of any GI visits, and lower annual rates of primary care, GI, DBP, and neurology visits. Hispanic/Latinx autistic children had significantly higher odds of any primary care, DBP, and neurology visits, but lower odds of psychiatry/psychology visits; and higher annual rates of neurology visits, but lower annual rates of GI, DBP, and psychiatry/psychology visits. Conclusions We found significant differences by sex, race, and ethnicity in non-acute healthcare use by autistic children. En ligne : https://doi.org/10.1016/j.rasd.2022.101951 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=476
in Research in Autism Spectrum Disorders > 94 (June 2022) . - 101951[article] Effects of sex, race, and ethnicity on primary and subspecialty healthcare use by autistic children in Florida: A longitudinal retrospective cohort study (2012?2018) [Texte imprimé et/ou numérique] / Amber M. ANGELL, Auteur ; Deepthi S. VARMA, Auteur ; Alexis DEAVENPORT-SAMAN, Auteur ; Larry YIN, Auteur ; Olga SOLOMON, Auteur ; Chen BAI, Auteur ; Baiming ZOU, Auteur . - 101951.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 94 (June 2022) . - 101951
Mots-clés : Autism spectrum disorders Sex/gender Healthcare utilization Index. décimale : PER Périodiques Résumé : Background Autistic children and youth have high rates of co-occurring conditions,but little is known about how autism subgroups (girls, non-White children) access healthcare to treat them. The purpose of this longitudinal retrospective cohort study was to investigate differences by sex, race, and ethnicity in non-acute (primary and subspecialty) healthcare use by autistic children and youth. Method We used the OneFlorida Data Trust to measure healthcare use for 82,566 autistic children ages 1?21 (2012?2018). We investigated (1) the odds of using any healthcare and (2) annual healthcare usage rates. We adopted a logistic regression and multiple linear regression for each of the dependent variables (total non-acute, primary care, gastroenterology (GI), developmental-behavioral pediatrics (DBP), psychiatry/psychology, neurology, and total subspecialty visits), adjusting for potential confounders (sex, race, ethnicity, age at visit, insurance type, urbanicity, and co-occurring conditions). Results Autistic boys had significantly higher odds of any neurology and psychiatry/psychology visits, but lower annual rates of primary care, GI, and neurology visits. Black/African American autistic children had significantly higher odds of any primary care, DBP, and neurology visits, but lower odds of any GI visits, and lower annual rates of primary care, GI, DBP, and neurology visits. Hispanic/Latinx autistic children had significantly higher odds of any primary care, DBP, and neurology visits, but lower odds of psychiatry/psychology visits; and higher annual rates of neurology visits, but lower annual rates of GI, DBP, and psychiatry/psychology visits. Conclusions We found significant differences by sex, race, and ethnicity in non-acute healthcare use by autistic children. En ligne : https://doi.org/10.1016/j.rasd.2022.101951 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=476 Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study / C. CROTEAU in Autism, 23-8 (November 2019)
[article]
Titre : Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study Type de document : Texte imprimé et/ou numérique Auteurs : C. CROTEAU, Auteur ; Laurent MOTTRON, Auteur ; M. DORAIS, Auteur ; J. E. TARRIDE, Auteur ; S. PERREAULT, Auteur Article en page(s) : p.2020-2030 Langues : Anglais (eng) Mots-clés : age variation autism spectrum disorder economic costs health services healthcare utilization interventions-pharmacologic predictors psychiatric costs psychoactive drugs Index. décimale : PER Périodiques Résumé : A number of cross-sectional studies report extensive use of psychiatric services and high healthcare costs in autistic youths. However, little is known about how the use of these services evolves from the time of diagnosis, as children grow up. Our objectives were to investigate the use, costs, and predictors of psychiatric services following autism spectrum diagnosis. We built a cohort of 1227 newly diagnosed autism spectrum individuals identified in the Quebec (Canada) Regie de l'assurance maladie du Quebec administrative database (January 1998 to December 2010). Mean number and cost per individual of psychiatric healthcare use (hospitalizations, medical visits, psychoactive drug use) were calculated yearly for 5 years following autism spectrum diagnosis. Mean number of psychiatric visits decreased over time by more than threefold (7.5 vs 2.1 visits) from year 1 to year 5, whereas psychoactive drug use increased from 16.0 to 25.2 claims. Psychiatric hospitalizations decreased during follow-up, but still represented the greatest costs per individual (CAD9820 for year 1; CAD4628 for year 5). Antipsychotics represented over 50% of drug costs. Mixed-effect model with repeated measures showed that previous psychoactive drug use was the strongest predictor of greater psychiatric healthcare cost during follow-up (odds ratio: 9.96; 95% confidence interval: 7.58-13.10). These trends contrast with guidelines advocating cautious prescribing of antipsychotics with periodical re-assessment of their benefit. En ligne : http://dx.doi.org/10.1177/1362361319840229 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=407
in Autism > 23-8 (November 2019) . - p.2020-2030[article] Use, costs, and predictors of psychiatric healthcare services following an autism spectrum diagnosis: Population-based cohort study [Texte imprimé et/ou numérique] / C. CROTEAU, Auteur ; Laurent MOTTRON, Auteur ; M. DORAIS, Auteur ; J. E. TARRIDE, Auteur ; S. PERREAULT, Auteur . - p.2020-2030.
Langues : Anglais (eng)
in Autism > 23-8 (November 2019) . - p.2020-2030
Mots-clés : age variation autism spectrum disorder economic costs health services healthcare utilization interventions-pharmacologic predictors psychiatric costs psychoactive drugs Index. décimale : PER Périodiques Résumé : A number of cross-sectional studies report extensive use of psychiatric services and high healthcare costs in autistic youths. However, little is known about how the use of these services evolves from the time of diagnosis, as children grow up. Our objectives were to investigate the use, costs, and predictors of psychiatric services following autism spectrum diagnosis. We built a cohort of 1227 newly diagnosed autism spectrum individuals identified in the Quebec (Canada) Regie de l'assurance maladie du Quebec administrative database (January 1998 to December 2010). Mean number and cost per individual of psychiatric healthcare use (hospitalizations, medical visits, psychoactive drug use) were calculated yearly for 5 years following autism spectrum diagnosis. Mean number of psychiatric visits decreased over time by more than threefold (7.5 vs 2.1 visits) from year 1 to year 5, whereas psychoactive drug use increased from 16.0 to 25.2 claims. Psychiatric hospitalizations decreased during follow-up, but still represented the greatest costs per individual (CAD9820 for year 1; CAD4628 for year 5). Antipsychotics represented over 50% of drug costs. Mixed-effect model with repeated measures showed that previous psychoactive drug use was the strongest predictor of greater psychiatric healthcare cost during follow-up (odds ratio: 9.96; 95% confidence interval: 7.58-13.10). These trends contrast with guidelines advocating cautious prescribing of antipsychotics with periodical re-assessment of their benefit. En ligne : http://dx.doi.org/10.1177/1362361319840229 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=407